News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HeraMED.
RELATED STOCKHEAD STORIES
News
CLOSING BELL: ASX adds 0.25%, Health Care remains on life support and GRE flew +223% on lithium chips news
News
ASX Small Caps Lunch Wrap: Has anyone else spotted a looming AI bubble today?
Health & Biotech
ASX Health Stocks: All about closing deals this morning as HeraMED and Careteq sign new contracts
Health & Biotech
ASX Health Stocks: Paradigm Bio says drug effective in dogs, HeraMED signs deal in US
Health & Biotech
ASX Health Stocks: A good day for women’s healthcare with big news from HeraMED and Ecofibre
Health & Biotech
ASX Health Stocks: HeraMED is traveling smoothly in the US; Recce names Adelaide firm to run Phase1/2 trial
News
ASX Small Caps Lunch Wrap: Who else is looking for a unicorn this morning?
Health & Biotech
ASX Health Stocks: US FDA well pleased with Race Oncology; Mesoblast releases top line readouts of Phase 3
Health & Biotech
ASX Health Stocks: These three ASX biotechs get to strut their stuff with Bell Potter and Nature Portfolio
Health & Biotech
ASX Health Stocks: US market brings home the bacon for HeraMED and Respiri
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Closing Bell: Small caps up, big caps down as RBA says inflation to stay
Health & Biotech
ASX Health Stocks: HeraMED up 17pc and Mesoblast 12pc after strong study results
News
Top 10 at 10: Which ASX stocks are sailing and sinking today?
Health & Biotech
ASX Health Stocks: HeraMED signs major deal for pregnancy monitoring platform
Health & Biotech
ASX Health Stocks: Proteomics jumps 13pc on diabetes test
Health & Biotech